EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131 I mIBG treatment of neuroendocrine tumours

EJNMMI Physics
Jonathan I GearEANM Dosimetry Committee

Abstract

The purpose of the EANM Dosimetry Committee Series on "Standard Operational Procedures for Dosimetry" (SOP) is to provide advice to scientists and clinicians on how to perform patient-specific absorbed dose assessments. This SOP describes image and data acquisition parameters and dosimetry calculations to determine the absorbed doses delivered to whole-body, tumour and normal organs following a therapeutic administration of 131I mIBG for the treatment of neuroblastoma or adult neuroendocrine tumours. Recommendations are based on evidence in recent literature where available and on expert opinion within the community. This SOP is intended to promote standardisation of practice within the community and as such is based on the facilities and expertise that should be available to any centre able to perform specialised treatments with radiopharmaceuticals and patient-specific dosimetry. A clinical example is given to demonstrate the application of the absorbed dose calculations.

References

Dec 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L S LashfordD Ackery
Nov 1, 1994·Annals of Nuclear Medicine·Y Nakabeppu, M Nakajo
Sep 2, 1998·Physics in Medicine and Biology·J S Fleming, A S Alaamer
Dec 16, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T KlingebielR Handgretinger
Oct 4, 2002·Physics in Medicine and Biology·Glenn D FluxMaggie A Flower
Apr 2, 2003·Cancer Biotherapy & Radiopharmaceuticals·Glenn D FluxSimon T Meller
Apr 2, 2003·Cancer Biotherapy & Radiopharmaceuticals·Michael LjungbergSven-Erik Strand
Aug 27, 2003·Health Physics·Michael G Stabin, Jeffry A Siegel
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven G DuBoisKatherine K Matthay
Mar 22, 2005·Cancer Biotherapy & Radiopharmaceuticals·Antigoni DivoliGlenn Flux
Nov 9, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Rachel K BodeyGlenn D Flux
Mar 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Katherine K MatthayJohn M Maris
Jan 1, 1991·IEEE Transactions on Medical Imaging·K OgawaS Hashimoto
Feb 16, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Francesco GiammarileUNKNOWN EANM
Jan 24, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Antigoni DivoliManuel Bardiès
Mar 17, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Rebecca A GregoryGlenn D Flux
Aug 29, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Susan E BuckleyGlenn D Flux
Apr 23, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Massimo Salvatori, Giovanni Lucignani
Apr 23, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Cecilia HindorfUNKNOWN EANM Dosimetry Committee
Aug 28, 2010·European Journal of Nuclear Medicine and Molecular Imaging·M LassmannUNKNOWN EANM Dosimetry Committee
Apr 13, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Mark Lubberink, Hans Herzog
Aug 2, 2011·Seminars in Nuclear Medicine·Shankar Vallabhajosula, Anastasia Nikolopoulou
Jan 6, 2012·Physics in Medicine and Biology·N LanconelliM Cremonesi
Jan 2, 2013·Nuclear Medicine Communications·Eoin O'Mahoney, Iain Murray
Oct 17, 2013·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Yuni K DewarajaBarry W Wessels
Sep 5, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Richard L WahlMark S Kaminski
Oct 18, 2015·European Journal of Nuclear Medicine and Molecular Imaging·Stefano Fanti, Elisabetta Lalumera
Mar 8, 2016·Physics in Medicine and Biology·Pablo MínguezKatarina Sjögreen Gleisner
Jan 13, 2018·EJNMMI Physics·Carlos F UribeAnna Celler
Sep 16, 2018·European Journal of Nuclear Medicine and Molecular Imaging·Jonathan I GearGlenn D Flux

❮ Previous
Next ❯

Citations

Dec 22, 2020·Nihon Hoshasen Gijutsu Gakkai zasshi·Kohei HanaokaHiroyuki Tsushima
Dec 8, 2020·Clinical Oncology : a Journal of the Royal College of Radiologists·M Bardiès, J I Gear
Oct 16, 2020·European Journal of Nuclear Medicine and Molecular Imaging·Mark KonijnenbergMichael Lassmann

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation

Software Mentioned

Bexxar
MIRD
OSEM
EXM
OLINDA
RADAR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.